Planet 13 Holdings (PLNH) Other Operating Expenses (2022 - 2026)
Planet 13 Holdings' (PLNH) quarterly Other Operating Expenses came in at -$969876.0 in Q1 2026, up 28.43% year-on-year from -$755151.1 in Q1 2025, and down 209.97% on a QoQ basis from $881912.0 in Q4 2025.
Planet 13 Holdings (PLNH) Other Operating Expenses (2022 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 5 years of Other Operating Expenses data on file, last reported at -$969876.0 in Q1 2026.
- On a quarterly basis, Other Operating Expenses rose 28.43% year-over-year to -$969876.0 in Q1 2026; TTM through Mar 2026 was $27.9 million, a 40.89% increase from a year earlier, with the FY2025 full-year figure at $33.0 million, up 22.37% from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$969876.0, down from $881912.0 in the prior quarter.
- Over the last five years, Other Operating Expenses for PLNH reached as high as $38.2 million in Q3 2023 and fell as low as -$1.7 million in Q3 2022.
- Historically, Other Operating Expenses has averaged $7.2 million across 5 years, with a median of -$783930.0 in 2024.
- On a YoY basis, Other Operating Expenses climbed as much as 3137.2% in 2025 and fell as far as 178.25% in 2025.
- Year by year, Other Operating Expenses stood at $34.9 million in 2022, then plunged by 75.14% to $8.7 million in 2023, then jumped by 138.54% to $20.7 million in 2024, then plunged by 95.75% to $881912.0 in 2025, then slumped by 209.97% to -$969876.0 in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were -$969876.0 in Q1 2026, $881912.0 in Q4 2025, and $29.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -969,876.00 |
| Dec 31, 2025 | 881,912.00 |
| Sep 30, 2025 | 29.07 Mn |
| Jun 30, 2025 | -1.08 Mn |
| Mar 31, 2025 | -1.36 Mn |
| Dec 31, 2024 | 20.73 Mn |
| Sep 30, 2024 | -957,206.00 |
| Jun 30, 2024 | 1.39 Mn |
| Mar 31, 2024 | -783,930.00 |
| Dec 31, 2023 | 8.69 Mn |
| Sep 30, 2023 | 38.16 Mn |
| Jun 30, 2023 | -1.34 Mn |
| Mar 31, 2023 | -1.28 Mn |
| Dec 31, 2022 | 34.95 Mn |
| Sep 30, 2022 | -1.67 Mn |
| Jun 30, 2022 | -1.60 Mn |
| Mar 31, 2022 | -639,164.00 |